| Ytd | -45.45% | |
| 1y | -88.58% |
| Open | 3.21 | Prev Close | 3.27 | Low | 3.16 | High | 3.31 | Mkt Cap | 1.11M |
| Vol | 11.97K | Avg Vol | 2.05M | EPS | -45.28 | P/E | -0.07 | Forward P/E | -0.73 |
| Beta | 2.32 | Short Ratio | 0.28 | Inst. Own | 3.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.55 | 200-d Avg | 7.42 | 1yr Est | 3.00 |
HCWB News
MIRAMAR, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strateg
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
MIRAMAR, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics
Company completed 28 consecutive trading days above $1.00 per share on June 25, 2026 Reverse stock s
HCW Biologics Inc. (NASDAQ:HCWB) stock fell during Tuesday's session. The company announced prelimin
Potentially best-in-class IL-2 based treatment for autoimmune diseases by expanding and activating r
Positions the Company to participate in fast-growing, multi-billion-dollar CAR-T immunotherapy marke
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), an investment banking
MIRAMAR, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $
US stocks down, S&P 500 falls 1%; Dow down 1.08%, NASDAQ down 1.42%. Energy shares up 1.5%; mate
Dow Jones falls 500 points, S&P drops 1.29%, NASDAQ down 1.79%. Energy shares rise 1.2%, tech st
Figma Inc (NYSE: FIG) shares rose 10.6% in pre-market trading after beating Q1 revenue and earnings
HCW Biologics Inc. surged 122.55% in after-hours trading after reporting first-quarter EPS that shar
MIRAMAR, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”
HCW11-040 is a pembrolizumab-based fusion immunotherapeutic that activates immune cells and eliminat
MIRAMAR, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologic
Its lead T-Cell Engager HCW11-018b is shown to penetrate into the tumor microenvironment with potent
Amazon may acquire Globalstar Inc., shares soared in pre-market trading. Other gainers include Turbo
MIRAMAR, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologic
HCW Biologics (NASDAQ: HCWB - Get Free Report) is expected to be announcing its results before the m
Upfront cash fee with total value of $7.0 million, comprised of a $3.5 million cash payment and $3.5
Commercialization ready compound supports a new method of generating highly functional human CAR-T c
MIRAMAR, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologic
MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB),
